Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry

Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which wo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied radiation and isotopes 2020-12, Vol.166, p.109364-109364, Article 109364
Hauptverfasser: Karampiperi, Maria, Tsirliganis, Nestor C., Kazakis, Nikolaos A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109364
container_issue
container_start_page 109364
container_title Applied radiation and isotopes
container_volume 166
creator Karampiperi, Maria
Tsirliganis, Nestor C.
Kazakis, Nikolaos A.
description Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which would allow to identify the prior presence of radioactive materials at buildings, sites or even vehicles. To this direction, several solid-state drugs, which are ubiquitous, have also been studied as probes for the dose estimation in emergency situations. However, due to their heat-sensitive character, measurements were possible only with OSL. The scope of the present work is to identify a heat-resistant drug (Daktarin) and conduct, for the first time, a detailed study of the thermoluminescence properties of it along with computerized curve deconvolution analysis which would shed light on the traps involved. Results indicate that the glow curve of Daktarin has at least three peaks that can be used for dosimetric purposes, since they exhibit linear dose response for doses up to 20 Gy, do not exhibit any sensitization, have high lifetime and their stability with time is good, since an appreciable signal remains unaffected even 3 months post irradiation. All the above were validated conducting dose recovery tests and successfully calculating the unknown delivered dose for various periods after the irradiation of the samples. The new findings are very supportive and point towards the efficient use of commercial pharmaceuticals as probes for retrospective/accidental/forensic dosimetry using thermoluminescence. •Daktarin@ is explored towards its use at retrospective/post-sterilization dosimetry.•TL dose response can be fitted with a linear function for doses up to 20 Gy.•The minimum detectable dose is less than 5 mGy.•A significant signal remains stored even 3 months after its irradiation.•Dose recovery tests were successfully conducted.
doi_str_mv 10.1016/j.apradiso.2020.109364
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2436874245</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S096980432030511X</els_id><sourcerecordid>2436874245</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-21f64c1d31152f018863cdec75c7eb7f777332a14e2887cd60c463f673512b4a3</originalsourceid><addsrcrecordid>eNqFkE1u2zAQhYmiAeo6uUKgZbqQzT-R1K5FmqQBAnRTrwl6OGroSqJKSgFyqRwiJwsNt-usBjPz3mDeR8gloxtGmdoeNm5KzoccN5zy47AVSn4gK2Y0r1tD6Ueyoq1qa0Ol-EQ-53yglErT8hVZdhmr2FUQhwETBNdX06NLgwNc5gCl9Wn5XV19d39ml8L4-vKl6mKqEs4p5glhDk-4dQDB4zi7fluWOOYA1fyIaYj9MoQRM-AIWPmYw1CMz-fkrHN9xot_dU12tze_rn_UDz_v7q-_PdQgZDPXnHVKAvOCsYZ3lBmjBHgE3YDGve601kJwxyRyYzR4RUEq0SktGsb30ok1uTrdnVL8u2Ce7RDKL33vRoxLtlwKZbTksilSdZJCyZUTdnZKYXDp2TJqj5ztwf7nbI-c7YlzMX49GbEEeQqYbIZwjOtDKnisj-G9E28lqo0G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2436874245</pqid></control><display><type>article</type><title>Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Karampiperi, Maria ; Tsirliganis, Nestor C. ; Kazakis, Nikolaos A.</creator><creatorcontrib>Karampiperi, Maria ; Tsirliganis, Nestor C. ; Kazakis, Nikolaos A.</creatorcontrib><description>Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which would allow to identify the prior presence of radioactive materials at buildings, sites or even vehicles. To this direction, several solid-state drugs, which are ubiquitous, have also been studied as probes for the dose estimation in emergency situations. However, due to their heat-sensitive character, measurements were possible only with OSL. The scope of the present work is to identify a heat-resistant drug (Daktarin) and conduct, for the first time, a detailed study of the thermoluminescence properties of it along with computerized curve deconvolution analysis which would shed light on the traps involved. Results indicate that the glow curve of Daktarin has at least three peaks that can be used for dosimetric purposes, since they exhibit linear dose response for doses up to 20 Gy, do not exhibit any sensitization, have high lifetime and their stability with time is good, since an appreciable signal remains unaffected even 3 months post irradiation. All the above were validated conducting dose recovery tests and successfully calculating the unknown delivered dose for various periods after the irradiation of the samples. The new findings are very supportive and point towards the efficient use of commercial pharmaceuticals as probes for retrospective/accidental/forensic dosimetry using thermoluminescence. •Daktarin@ is explored towards its use at retrospective/post-sterilization dosimetry.•TL dose response can be fitted with a linear function for doses up to 20 Gy.•The minimum detectable dose is less than 5 mGy.•A significant signal remains stored even 3 months after its irradiation.•Dose recovery tests were successfully conducted.</description><identifier>ISSN: 0969-8043</identifier><identifier>EISSN: 1872-9800</identifier><identifier>DOI: 10.1016/j.apradiso.2020.109364</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Accidental dosimetry ; Daktarin ; Deconvolution ; Dosimetry ; Drugs ; Pharmaceuticals ; Thermoluminescence</subject><ispartof>Applied radiation and isotopes, 2020-12, Vol.166, p.109364-109364, Article 109364</ispartof><rights>2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-21f64c1d31152f018863cdec75c7eb7f777332a14e2887cd60c463f673512b4a3</citedby><cites>FETCH-LOGICAL-c345t-21f64c1d31152f018863cdec75c7eb7f777332a14e2887cd60c463f673512b4a3</cites><orcidid>0000-0001-5831-1029 ; 0000-0001-7804-2540</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.apradiso.2020.109364$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids></links><search><creatorcontrib>Karampiperi, Maria</creatorcontrib><creatorcontrib>Tsirliganis, Nestor C.</creatorcontrib><creatorcontrib>Kazakis, Nikolaos A.</creatorcontrib><title>Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry</title><title>Applied radiation and isotopes</title><description>Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which would allow to identify the prior presence of radioactive materials at buildings, sites or even vehicles. To this direction, several solid-state drugs, which are ubiquitous, have also been studied as probes for the dose estimation in emergency situations. However, due to their heat-sensitive character, measurements were possible only with OSL. The scope of the present work is to identify a heat-resistant drug (Daktarin) and conduct, for the first time, a detailed study of the thermoluminescence properties of it along with computerized curve deconvolution analysis which would shed light on the traps involved. Results indicate that the glow curve of Daktarin has at least three peaks that can be used for dosimetric purposes, since they exhibit linear dose response for doses up to 20 Gy, do not exhibit any sensitization, have high lifetime and their stability with time is good, since an appreciable signal remains unaffected even 3 months post irradiation. All the above were validated conducting dose recovery tests and successfully calculating the unknown delivered dose for various periods after the irradiation of the samples. The new findings are very supportive and point towards the efficient use of commercial pharmaceuticals as probes for retrospective/accidental/forensic dosimetry using thermoluminescence. •Daktarin@ is explored towards its use at retrospective/post-sterilization dosimetry.•TL dose response can be fitted with a linear function for doses up to 20 Gy.•The minimum detectable dose is less than 5 mGy.•A significant signal remains stored even 3 months after its irradiation.•Dose recovery tests were successfully conducted.</description><subject>Accidental dosimetry</subject><subject>Daktarin</subject><subject>Deconvolution</subject><subject>Dosimetry</subject><subject>Drugs</subject><subject>Pharmaceuticals</subject><subject>Thermoluminescence</subject><issn>0969-8043</issn><issn>1872-9800</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1u2zAQhYmiAeo6uUKgZbqQzT-R1K5FmqQBAnRTrwl6OGroSqJKSgFyqRwiJwsNt-usBjPz3mDeR8gloxtGmdoeNm5KzoccN5zy47AVSn4gK2Y0r1tD6Ueyoq1qa0Ol-EQ-53yglErT8hVZdhmr2FUQhwETBNdX06NLgwNc5gCl9Wn5XV19d39ml8L4-vKl6mKqEs4p5glhDk-4dQDB4zi7fluWOOYA1fyIaYj9MoQRM-AIWPmYw1CMz-fkrHN9xot_dU12tze_rn_UDz_v7q-_PdQgZDPXnHVKAvOCsYZ3lBmjBHgE3YDGve601kJwxyRyYzR4RUEq0SktGsb30ok1uTrdnVL8u2Ce7RDKL33vRoxLtlwKZbTksilSdZJCyZUTdnZKYXDp2TJqj5ztwf7nbI-c7YlzMX49GbEEeQqYbIZwjOtDKnisj-G9E28lqo0G</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Karampiperi, Maria</creator><creator>Tsirliganis, Nestor C.</creator><creator>Kazakis, Nikolaos A.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5831-1029</orcidid><orcidid>https://orcid.org/0000-0001-7804-2540</orcidid></search><sort><creationdate>202012</creationdate><title>Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry</title><author>Karampiperi, Maria ; Tsirliganis, Nestor C. ; Kazakis, Nikolaos A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-21f64c1d31152f018863cdec75c7eb7f777332a14e2887cd60c463f673512b4a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Accidental dosimetry</topic><topic>Daktarin</topic><topic>Deconvolution</topic><topic>Dosimetry</topic><topic>Drugs</topic><topic>Pharmaceuticals</topic><topic>Thermoluminescence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karampiperi, Maria</creatorcontrib><creatorcontrib>Tsirliganis, Nestor C.</creatorcontrib><creatorcontrib>Kazakis, Nikolaos A.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Applied radiation and isotopes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karampiperi, Maria</au><au>Tsirliganis, Nestor C.</au><au>Kazakis, Nikolaos A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry</atitle><jtitle>Applied radiation and isotopes</jtitle><date>2020-12</date><risdate>2020</risdate><volume>166</volume><spage>109364</spage><epage>109364</epage><pages>109364-109364</pages><artnum>109364</artnum><issn>0969-8043</issn><eissn>1872-9800</eissn><abstract>Retrospective/accidental dosimetry seeks for materials that can be used as probes for the dose assessment by means of several methods when there is no dose data available (e.g. from personal dosimeters). In the same respect, researchers also seek materials appropriate for forensic purposes, which would allow to identify the prior presence of radioactive materials at buildings, sites or even vehicles. To this direction, several solid-state drugs, which are ubiquitous, have also been studied as probes for the dose estimation in emergency situations. However, due to their heat-sensitive character, measurements were possible only with OSL. The scope of the present work is to identify a heat-resistant drug (Daktarin) and conduct, for the first time, a detailed study of the thermoluminescence properties of it along with computerized curve deconvolution analysis which would shed light on the traps involved. Results indicate that the glow curve of Daktarin has at least three peaks that can be used for dosimetric purposes, since they exhibit linear dose response for doses up to 20 Gy, do not exhibit any sensitization, have high lifetime and their stability with time is good, since an appreciable signal remains unaffected even 3 months post irradiation. All the above were validated conducting dose recovery tests and successfully calculating the unknown delivered dose for various periods after the irradiation of the samples. The new findings are very supportive and point towards the efficient use of commercial pharmaceuticals as probes for retrospective/accidental/forensic dosimetry using thermoluminescence. •Daktarin@ is explored towards its use at retrospective/post-sterilization dosimetry.•TL dose response can be fitted with a linear function for doses up to 20 Gy.•The minimum detectable dose is less than 5 mGy.•A significant signal remains stored even 3 months after its irradiation.•Dose recovery tests were successfully conducted.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.apradiso.2020.109364</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5831-1029</orcidid><orcidid>https://orcid.org/0000-0001-7804-2540</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0969-8043
ispartof Applied radiation and isotopes, 2020-12, Vol.166, p.109364-109364, Article 109364
issn 0969-8043
1872-9800
language eng
recordid cdi_proquest_miscellaneous_2436874245
source ScienceDirect Journals (5 years ago - present)
subjects Accidental dosimetry
Daktarin
Deconvolution
Dosimetry
Drugs
Pharmaceuticals
Thermoluminescence
title Use of commercial pharmaceutical drug (Daktarin®) for retrospective/accidental/forensic thermoluminescence dosimetry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A18%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20commercial%20pharmaceutical%20drug%20(Daktarin%C2%AE)%20for%20retrospective/accidental/forensic%20thermoluminescence%20dosimetry&rft.jtitle=Applied%20radiation%20and%20isotopes&rft.au=Karampiperi,%20Maria&rft.date=2020-12&rft.volume=166&rft.spage=109364&rft.epage=109364&rft.pages=109364-109364&rft.artnum=109364&rft.issn=0969-8043&rft.eissn=1872-9800&rft_id=info:doi/10.1016/j.apradiso.2020.109364&rft_dat=%3Cproquest_cross%3E2436874245%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2436874245&rft_id=info:pmid/&rft_els_id=S096980432030511X&rfr_iscdi=true